The proliferative and migratory effects of physical injury and stromal cell-derived factor-1α on rat cardiomyocytes and fibroblasts

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 7, 2015, Pages 1252-1257

  Hou, C J ^a   Qi, Y M ^a   Zhang, D Z ^a   Wang, Q G ^a   Cui, C S ^a   Kuang, L ^a   Chen, B ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Cardiac fibroblasts; Cardiomyocytes; Physical injury; Stromal cell derived factor 1

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; HEART CELL CULTURE; HEART FIBROBLAST; HEART INJURY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIMARY CELL CULTURE; RAT; ANIMAL; CELL CULTURE; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; FIBROBLAST; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84940737986     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. THANOPOULOS BV, RIGBY ML, KARANASIONS E, STEFANADIS C, BLOM N, OTTENKAMP J, ZARAYELYAN A. Transcatheter closure of perinembranous ventricular septal defect in infant and children using the Amplatzer perimembranuous ventrieular septal defect occluder. Am J Cardiol 2007;99:984-989.
2. BUTERA G, PIAZZA L, SARACINO A, CHESSA M, CARMINATI M. Transcatheter closure of membranous ventricular septal defects-old problems and new solutions. Interventional Cardiol Clin 2013;2:85-91.
3. ZHANG G, NAKAMURA Y, WANG X, HU Q, SUGGS LJ, ZHANG J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007;13:2063-2071.
4. MAJUNKE N, BIALKOWSKI J, WILSON N, SZKUTNIK M, KUSA J, BARANOWSKI A, HEINISCH C, OSTERMAYER S, WUNDERLICH N, SIEVERT H. Closure of atrial septal defect with the amplatzer septal occluder in adults. Am J Cardiol 2009;103:550-554.
5. BIJULAL S, SIVASANKARAN S, AJITKUMAR VK. An unusual thrombotic complication during percutaneous closure of atrial septal defect. J Invasive Cardiol 2009;21:83-85.
6. ERO LU AG, OZTUNÇ F, SALTIK L, BAKARI S, DEDEO LU S, AHUNBAY G. Evolution of ventricular septal defect with special reference to spontaneous closure rate, subaortic ridge and aortic valve prolapse. Pediatr Cardiol 2003;24:31-35.
7. DE FALCOL M, COBELLIS G, DE LUCA A. Proliferation of cardiomyocytes: a question unresolved. Front Biosci (Elite Ed) 2009;1:528-536.
8. GOLDSMITH EC, HOFFMAN A, MORALES MO, POTTS JD, PRICE RL, MCFADDEN A, RICE M, BORG TK. Organization of fibroblasts in the heart. Dev Dyn 2004;230:787-794.
9. SOUDERS C, BOWERS SL, BAUDINO TA. Cardiac fibroblasts: the renaissance cell. Circ Res 2009;105:1164-1176.
10. PORTER KE, TURNER NA. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther 2009;123:255-278.
11. PORTAL L, MARTIN V, ASSALY R, D'ANGLEMONT DE TASSIGNY A, MICHINEAU S, BERDEAUX A, GHALEH B, PONS S. A Model of hypoxia-reoxygenation on isolated adult mouse cardiomyocytes: characterization, comparison with ischemia-reperfusion, and application to the cardioprotective effect of regular treadmill exercise. J Cardiovasc Pharmacol Ther 2013;18:367-375.
12. YU Y, WANG S, NIE B, SUN Y, YAN Y, ZHU L. Effect of astragali radix injection on myocardial cell mitochondrial structure and function in process of reversing myocardial cell hypertrophy. China J Chin Mater Med 2012;37:979-984.
13. DONG Y, ZHANG L, SHAO SX, YIN Q, CHEN W, ZHAO CF. The study of myocardial-like tissue engineering constructed by fibroblasts of ischemia myocardium. Chin J Cell Biol 2010;32:361-369.
14. LIEHN EA, TUCHSCHEERER N, KANZLER I, DRECHSLER M, FRAEMOHS L, SCHUH A, KOENEN RR, ZANDER S, SOEHNLEIN O, HRISTOV M, GRIGORESCU G, URS AO, LEABU M, BUCUR I, MERX MW, ZERNECKE A, EHLING J, GREMSE F, LAMMERS T, KIESSLING F, BERNHAGEN J, SCHOBER A, WEBER C. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011;58:2415-2423.
15. TANG JM, WANG JN, SONG HX, HUANG Y, YANG J, KONG X, GUO L, ZHENG F, ZHANG L. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep 2010;37:1957-1969.
16. YIN Q, JIN PF, LIU XB, WEI H, LIN X, CHI C, LIU Y, SUN C, WEI Y. SDF-1a inhibits hypoxia and serum deprivationinduced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep 2011;38:9-16.
17. SHEN L, GAO YX, QIAN JY, WU Y, ZHOU M, SUN A, ZOU Y, GE J. The role of SDF-1a/Rac pathway in the regulation of endothelial progenitor cell polarity, homing and expression of Rac1, Rac2 during endothelial repair. Mol Cell Biochem 2012;365:1-7.
18. DAISY P, WANG CC. Stromal-drived fctor-1 aphaloaded PLGA microspheres for stem cell recruitment. Pharm Res 2011;28:2477-2489.
19. WANG YB, LIU YF, LU XT, YAN FF, WANG B, BAI WW, ZHAO YX. Rehmannia glutinosa extract activates endothelial progenitor cells in a rat model of myocardial infarction through a SDF-1 α/CXCR4 cascade. PLoS One 2013;8:e54303.
20. JIN F, BROCKMEIER U, OTTERBACH F, METZEN E. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: Hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 2012;10:1021-1031.